Eckhoff, A. M., Kanu, E., Bao, M., Blazer, D. G., Zani, S., Lidsky, M. E., … Nussbaum, D. P. (2023). Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy. Ann Surg Oncol, 30(6), 3194–3196. https://doi.org/10.1245/s10434-023-13318-5

Eckhoff, Austin M., Elishama Kanu, Matthew Bao, Dan G. Blazer, Sabino Zani, Michael E. Lidsky, Peter J. Allen, and Daniel P. Nussbaum. “Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy.” Ann Surg Oncol 30, no. 6 (June 2023): 3194–96. https://doi.org/10.1245/s10434-023-13318-5.

Eckhoff AM, Kanu E, Bao M, Blazer DG, Zani S, Lidsky ME, et al. Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy. Ann Surg Oncol. 2023 Jun;30(6):3194–6.

Eckhoff, Austin M., et al. “Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy.” Ann Surg Oncol, vol. 30, no. 6, June 2023, pp. 3194–96. Pubmed, doi:10.1245/s10434-023-13318-5.

Eckhoff AM, Kanu E, Bao M, Blazer DG, Zani S, Lidsky ME, Allen PJ, Nussbaum DP. Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy. Ann Surg Oncol. 2023 Jun;30(6):3194–3196.